The MMP-9:TIMP-1 complex was quantified in preoperatively obtained plasma samples from 465 patients with primary breast cancer using a classical commercially available sandwich ELISA, which had not been validated for use with plasma samples by the supplier, and using the recently developed in-solution Proximity Ligation Assay (PLA, Figure 1). This evidence concerns the gene MMP9 and breast cancer.